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ABSTRACT 
Introduction: The Liebowitz Social Anxiety Scale 
(LSAS), used to assess the severity of social anxiety 
disorder (SAD), requires considerable effort and time 
to complete. The aims of this study were: 1) to inves-
tigate whether a visual analogue scale (VAS) could be 
linear with the LSAS and substitute for the LSAS, 2) 
to relate such a VAS instrument to patient demo-
graphics. Methods: Fifty SAD patients were assessed 
using the LSAS and VAS instruments completed by 
both patients and doctors at the same session. We 
then drew distributions and calculated the Spear-
man’s ρ and κ coefficient values (divided at the me-
dian for each scale) between patient and doctor as-
sessments. Next, each pair among the scores for the 
LSAS, the patient VAS and the doctor VAS was 
compared using Wilcoxon rank sum tests according 
to patient life profile data. Results: Scatter plots of 
pairs of scores were obtained. Spearman’s ρ was 
0.661 between the LSAS and the patient VAS, 0.461 
between the LSAS and the doctor VAS, and 0.494 
between VAS scores of patients and doctors. The κ 
coefficients were 0.501 between the LSAS and patient 
VAS, 0.251 between the LSAS and doctor VAS, and 
0.425 between patient VAS and doctor VAS (for all 
six, p < 0.001). The Wilcoxon rank sum tests indicated 
a significant difference between the groups with/ 
without “employment” (LSAS, patient/doctor VAS), 
with/without “graduation from junior college/uni- 
versity” (doctor VAS) (p < 0.05) and with/without 
marital history (the age of first consultation) (p < 
0.01). Conclusions: A patient VAS may substitute for 
the LSAS and offer the versatility necessary to cap-
ture patient states and life profiles. 
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1. INTRODUCTION 
Social phobia or Social Anxiety Disorder (SAD) is a se-
rious mental disorder characterized by a number of 
symptoms. Currently, the Liebowitz Social Anxiety Scale 
is frequently used to assess the severity of patients with 
social phobia [1], generating a 24-item score for the last 
week. These items cover the two aspects of social inte-
raction and performance/observation situations, e.g., 
“Telephoning in public” and “Participating in small 
groups”, respectively. The sum of the scores in each do-
main expresses the overall severity. The reliability and 
validity of the LSAS have been extensively examined by 
many psychiatrists and the credibility of the LSAS has 
been supported [2-4]. However, in our experience, we 
often encounter the situation where the total score of the 
LSAS differs widely from our simple impression of the 
severity of a patient’s social phobia. In addition, the ef-
fort and time required to complete it may exceed the ca-
pacity of some patients. We also sometimes encounter 
situations where the characteristics of disease states are 
quite different from each other although patients may 
have almost the same score. Not only that, there are situ-
ations where there is a discrepancy between the assess-
ment performed by the doctor and that by the patient. In 
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the last type of situation, it may be important to find out 
what background tendencies or relationships are seen in 
certain patients with social phobia and be able to relate 
them to the above two aspects (symptoms levels in social 
interaction and performance/observation situations). To 
express an overall impression for the severity of illness, a 
number of well-known scales are used. The Clinical 
Global Impression of Severity for psychiatric disease [5], 
specifically, the CGI-SCH for schizophrenia [6], CGI-BP 
for bipolar illness [7], and CGI for social anxiety disord-
er [8], gives a score ranging from 1 to 7 in an ordinal 
scale. Visual analogue scales (VAS) are used to express 
the value of the total impression for the severity of ill-
ness (usually pain) by patients by making a mark deter-
mining a decimal number from 0 to 100 (mm) [9-12]. 
Numerical rating scales (NRS) are also utilized to dis-
play the value of the total impression for the severity of 
illness (usually pain) in a similar manner by determining 
an integer number from 0 to 10 [13,14] to substitute for 
the doctor’s/patient’s impression (although the true esti-
mation of the validity of both VAS and NRS is in flux at 
present [15-21]). 
Single-item VAS scales have been used in psycholog-
ical assessment since the early 20th century and have 
subsequently been employed successfully in the assess-
ment of a wide variety of health-related constructs in-
cluding pain [22-24], quality-of-life [25,26], mood 
[27,28], and anxiety [29-33]. VAS scales are brief and 
simple to administer and minimal in terms of respon-
dent burden. 
Until now, to our knowledge, there has been no report 
on providing an overall impression of SAD severity with 
VAS scale scores (either rated by patients for themselves 
or for patients rated by doctors) and of comparing these 
with LSAS scores. Evaluation scales that are relevant, 
quick, user-friendly, and graduated at equal intervals are 
needed to facilitate measurement-based treatment of so-
cial phobia. If the use of such VAS scales demonstrates a 
valid relationship with the LSAS, we might obtain 
another approach to assessing the characteristics of the 
differing disease states of social anxiety disorder simply 
and quickly. In addition, if there is a relationship between 
them, it might be possible to feed these results back to 
clinical treatment and research on SAD. It may also be 
possible to assess whether there are associations between 
the profiles of patients (e.g., male/female, with/without 
occupations, educational backgrounds, with/without co-
habiters). 
The aims of this study were two-fold: 1) to investigate 
whether a VAS could be in a good linear relationship 
with the LSAS, such that there is a possibility that the 
VAS could be versatile enough to substitute for the 
LSAS, even if only partially, 2) to study how such a pa-
tient VAS score is associated with patient life profiles 
(e.g., sex, with/without occupations, educational back-
grounds, with/without cohabiters). However, this was 
only a pilot study, and our main aims were to present a 
viewpoint and an approach that future studies would 
re-investigate and develop with more rigor. 
2. METHODS 
The LSAS is a 24-item scale that measures fear and/or 
anxiety and avoidance of social situations over the last 
week. It consists of 11 items relating to social interaction 
and 13 items related to public performance. Each item is 
rated 0, 1, 2 or 3 both for fear/anxiety and for avoidance, 
with the score for each item being the sum of the two 
parts and the total score for the LSAS being the sum of 
all 24 items. Our hypothesis was that the VAS score 
would have meaning as an indicator of the degree of se-
verity for SAD. 
2.1. Participants 
This is a prospective study of outpatients treated at the 
Tokyo Women’s Medical University Hospital, and Tokyo 
Women’s Medical University, Medical Center East, who 
met the DSM-IV-TR [34] criteria for SAD. A total of 50 
patients (23 males, 27 females) with mean age of 35.18 ± 
12.05 years (range, 18 - 73) were included in this study 
as a convenience sample between 26 January 2012 and 4 
July 2012. The present study was approved by the ethics 
committee of Tokyo Women’s Medical University, and 
all patients signed informed consent forms before partic-
ipating in the study. 
2.2. Research Design 
For these patients, the evaluations for SAD were per-
formed by the patients and by sixteen experienced doc-
tors independently (with patients and doctors blind to 
each other’s ratings) at the same session. The evaluation 
scales used in the study are “patient VAS” (evaluated by 
patients themselves in terms of their state, e.g., like Fig-
ure 1), “doctor VAS” (evaluated by doctors in terms of 
the patient’s state), and the LSAS completed by patients. 
At the same time, patient profiles and demographic in-
formation were collected, including age, sex, with/ 
without cohabiters, educational background, marital his- 
tory, employment status, year of first consultation, and 
 
 
Figure 1. The visual analogue scale. The degree of severity of 
the anxious disease state was marked within the range of 0 - 
100 (mm) by patients. A similar scale was also used by doctors 
to rate patients. 
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year of onset. Our intention was to compare the scores 
between the LSAS and the patient VAS (rated by pa-
tients themselves), then between the LSAS and the doc-
tor VAS, and finally between the patient VAS and the 
doctor VAS. We drew the scatter plot for all pairs of 
individual scores and calculated Spearman’s ρ using raw 
data and κ coefficients with cross tabulations divided at 
the medians of both the LSAS (72 points) and the VAS 
(50 points) for each pair (LSAS and patient VAS, LSAS 
and doctor VAS, patient VAS and doctor VAS). 
After that, for all patients, basic demographic statis-
tical data were displayed to survey for trends in terms 
of “age”, “sex”, “existence of marital history”, “exis-
tence of cohabiters”, “employment”, “graduation of 
junior college or university”, “the year of onset”, and 
“the age of first consultation (years)”. Additionally, 
Wilcoxon rank sum tests between age, sex, existence of 
marital history, existence of cohabiters, employment 
status, graduation of junior college or university, the 
age of onset, and the age of first consultation were per-
formed to examine for specific differences. We used 
SPSS for Windows, version 20 [35] for statistical anal-
ysis, Stata Release 10.0 [36] to draw scatter plots, and 
Microsoft Excel 2003 [37] for formatting the files. 
3. RESULTS 
The scatter plots between all pairs of individual scores 
for all 50 patients are shown in Figure 2. In Table 1, the 
Spearman’s ρ between the LSAS and patient VAS scores 
is 0.661 (p < 0.001), while that between the LSAS and 
doctor VAS scores is 0.461 (p < 0.001), and that between 
patient and doctor VAS scores is 0.494 (p < 0.001). In 
Table 2, κ coefficients between each pair of two scales 
are shown. Between the LSAS and patient VAS, the κ 
was 0.501 (p < 0.001), while it was 0.251 (p < 0.001) 
between the LSAS and doctor VAS scores and 0.425 (p 
< 0.001) between the patient and doctor VAS scores. For 
all 50 patients, mean scores for the LSAS were 76.00 ± 
28.53 (S.D.), while for the patient VAS and the doctor 
VAS, they were 52.58 ± 26.26 (S.D.) and 52.14 ± 25.48 
(S.D.), respectively. Basic patient demographic profiles 
are presented in Table 3. The Wilcoxon rank sum tests 
for patient demographics showed significant differences 
between the group with/without “employment” (LSAS, 
patient and doctor VAS), with/without “graduation of 
junior college/university” (doctor VAS) (p < 0.05) and 
with/without “marital history” (the age of first consulta-
tion) (p < 0.01) in Table 4, although the reproducibility 
is ambiguous at this stage because of our small sample 
data size. 
4. DISCUSSION 
This study was performed not only to examine the value  
 
Figure 2. Scatter plots for each pair of scales. The scatter plots 
between any pair of the scales among the LSAS, VAS rated by 
patients (denoted VP), and VAS rated by patients’ doctors (de-
noted VD) are presented (the mirror images are also illustrated). 
Abbreviations; VP: visual analogue scale (VAS) rated by pa-
tients, VD: VAS rated by doctors. 
 
Table 1. Spearman’s ρ between the two scales. 
 LSAS VP VD 
LSAS 1   
VP 0.661 1  
VD 0.461 0.494 1 
Abbreviations: VP: visual analogue scale (VAS) rated by patients; VD: VAS 
rated by doctors. Spearman’s ρ values expressing the degree of correlation 
between each pair (LSAS, patient VAS, doctor VAS) are presented. 
 
Table 2. κ coefficient between the two scales. 
 LSAS VP VD 
LSAS 1   
VP 0.501 1  
VD 0.251 0.425 1 
Abbreviations: VP: visual analogue scale (VAS) rated by patients; VD: 
VAS rated by doctors. The κ coefficients, expressing the degree of accor-
dance between each pair among 1) LSAS and patient VAS, 2) LSAS and 
doctor VAS, and 3) patient VAS and doctor VAS, are presented. 
 
of a VAS scale for SAD but also to clarify the characte-
ristics of the LSAS. The LSAS scale has been well- stu-
died [2-4] and our qualitative results demonstrated that 
SAD patients had no difficulties with the VAS format or 
with reporting global anxiety levels. Similar methods 
have been used in anesthesiology, [38,39] where the 
study was based on average pain levels over the last 24 
hours. Unexpectedly, to our knowledge, for severity of 
anxiety, no study has reported on VAS scales rated by 
patients for themselves and for patients by doctors at the  
lsastotal
patvastotal
psyvastotal
0
50
100
150
0 50 100 150
0
50
100
0 50 100
0
50
100
0 50 100
LSAS
VP
VD
Copyright © 2014 SciRes.                                                                       OPEN ACCESS 
H. Okitsu et al. / Open Journal of Psychiatry 4 (2014) 68-74 71 
Table 3. Essential data of patients’ life profiles and results of 
Wilcoxon rank sum tests. 
Life profiles  
of patients 
Total  
(n = 50) Category 
Significance  
for scale 
Age (years) Mean ± S.D. 35.18 ± 12.05   
Male/Female (n = 50) 46% (n = 23)/ 54% (n = 27) n.s. 
Existence of  
marital history/not (n = 50) 
28% (n = 14)/  
72% (n = 36) n.s. 
Existence of  
cohabiters/not (n = 50) 
84% (n = 42)/  
16% (n = 8) n.s. 
Employment/not (n = 50) 36% (n = 18)/ 64% (n = 32) 
s*  
(patient/doctor) 
Graduation of  
short college or 
university/not 
(n = 50) 42% (n = 21)/ 58% (n = 29) s
* (doctor) 
s*: significance for VAS (p < 0.05), s**: significance for VAS (p < 0.01), n.s.: 
non-significance for VAS (p ≥ 0.05) Abbreviations: VP: visual analogue 
scale (VAS) rated by patients; LSAS: Liebowitz Social Anxiety Scale. The 
essential data of patient life profiles (e.g., age, sex, existence of marital 
history.) are presented for 50 patients. There was a significant difference 
between with/without employment (LSAS, patient/doctor VAS) and with/ 
without graduation of junior college or university (doctor VAS) (p < 0.05). 
 
Table 4. The results of Wilcoxon rank sum tests. 
 Total  (n = 50) 
Marriage(n = 14) 
/not (n = 36)  
The age of  
onset (years) 19.86 ± 9.61 
24.21 ± 12.72/ 
18.17 ± 7.66 n.s. 
The age of first  
consultation (years) 27.00 ± 8.63 
33.93 ± 7.24/ 
24.31 ± 7.63 s
** 
s*: significance for years (p < 0.05), s**: significance for years (p < 0.01), 
n.s.: non-significance for years (p ≥ 0.05). There was a significant difference 
for first consultation (years) with/without marital history (p < 0.01). 
 
same session being compared with the LSAS, although 
VASs are used for pain, especially in anesthesiology, 
[12,13,38,39] and in some cases, dentistry [32]. In the 
psychiatric field, the Clinical Global Impression-Severity 
scale (CGI-S), for example, with schizophrenia (CGI- 
SCH), is usually used in daily clinical practice [5-8]. 
However, the consistency of calibration of these scales 
has not been proven. Furthermore, the CGIs are rated 
only by doctors while the VASs are ordinarily rated by 
patients themselves; in our view, both raters should be 
using the same-ranged/same-formed scale. The first rea-
son that we focused on the VAS was that we expected the 
VAS score to better reflect the patient’s genuine impres-
sion in a linear way. The second reason was that we con-
sidered the comparisons of patient-rated with doctor- 
rated VAS and of the patient-rated VAS with the LSAS 
necessary to most accurately assess the true severity of 
the patients’ disease states. As shown in the Results sec-
tion, there are good correlations between the LSAS and 
the patient VAS, although there may exist biases because 
of the small sample size of the data. In future, we might 
be able to substitute the patient VAS for the original 
LSAS at least in part. 
Based on the present study, the VAS score rated by 
doctors does not seem to have a good linear relationship 
(either in terms of Spearman’s ρ or κ coefficient), which 
might imply that doctors do not always perform a good 
assessment of patient states, such as severity, and that 
patients may have a better impression of their own state 
than their doctors. 
The Wilcoxon rank sum tests (Table 3) show that 
there were significant differences between the patient 
and doctor VAS for with/without “employment” and 
“education”. However, it is likely that there were poten-
tial influential confounder biases on the patients’ and 
doctors’ impressions since employment and education 
imply participation in society. For the age of first con-
sultation, that of patients with “marital history” is higher 
than that of patients without marital history (Table 4). 
This suggests that “marital history” is associated with 
supportive circumstances that could delay the age of first 
consultation for SAD patients. Whether this will be re-
producible is unclear. 
Although our findings may not be reproducible, one of 
our main purposes for this study was to propose a new 
approach for improving evaluation scales used in daily 
clinical practice. These often require more time and ef-
fort than is feasible for patients who do not have good 
mental states. We believe that there might be value for 
this kind of approach in the future. 
In summary, the results of the current study suggest 
that a patient VAS score for SAD could be a substitute 
option that requires less time and effort for rating patient 
severity. Doctors might be able to use such patient self- 
assessments of their disease states for more precise di-
agnosis and treatment, although further investigations are 
needed with more rigorous methodology. 
The limitations of the present study should be noted. 
The first was the use of the VAS as a scale that substi-
tuted for the evaluation made by the patients (and doc-
tors). There is no evidence that the VAS is a gold stan-
dard and that it has perfect linearity with the severity of 
patients’ disease states. The substitution of a patient VAS 
score is merely a tentative assumption to pursue a me-
thod to reduce the time and effort of patients in daily 
clinical examination. Even with the original VAS, as 
mentioned before, only a certain degree of reliability has 
been reported [15-21]. Nonetheless, we thought that this 
kind of simplification was unavoidable when designing 
the experiment and that the trade-off was necessary, al-
though this assumption might sacrifice rigor in exchange 
for a simpler expression of the degree of subjective se-
verity of a mental disease. 
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Second, there was no assurance that the assumption 
that the VAS scores obtained from many doctors had 
good inter-rater reliability was correct because this was 
not assessed. The exact reproducibility of the VAS score 
seems to be low because the values permitted are any 
real numbers from 0 to 100, which are infinite, so that 
the probability that the same score can be obtained even 
by the same doctor is almost zero. However, the proba-
bility that almost the same score can be obtained might 
be close to that of an eleven-grade scale using 0, 1, 2, 3, 
 , 9, 10 (the Numerical rating scale or NRS [13,14]). It 
may be, however, that the score determined freely within 
this range might be influenced by chance or other con-
tingent factors. 
Third, to our knowledge, the use of VAS scales is not 
established in the psychiatric field. Those supported by 
literature and statistical analysis are accepted in other 
fields of medicine such as anesthesiology and dentistry, 
as mentioned previously. Right from the start, it is un-
clear what meaning to assign to the score of 100 with the 
patient VAS. In our literature search, there was no rigor-
ous definition for the highest score 100 for the VAS 
when applied to mental states. In previous articles using 
the VAS scale, it is ambiguous whether 100 means “the 
worst possible anxious disease state that can be imagined” 
or “the most severe anxious state that is experienced by 
the patient (or doctor) so far”. We presume that one of 
the outcomes of psychiatric treatment is a subjective im-
pression of patient improvement, such as the VAS rated 
by the patient (or, in some cases, the VAS rated by their 
families). Therefore, there may be valid meaning in the 
range of 0 - 100 even when the meaning of the edges (0 
or 100 points) is difficult to define concretely. Therefore, 
a “VAS-I” (VAS for improvement, a scale not currently 
established) by patients (or their families) might play a 
role in the future, although such a scale might have other 
problems, e.g., “reproducibility”. For these reasons, the 
best definitions of the maximum score 100 for a patient 
VAS will depend upon future study. 
Fourth and finally, because a biomarker that indicates 
quantitative degrees of severity for anxiety has not been 
detected, evaluation scales such as those in the present 
article must substitute at present for all patients. If such a 
biomarker does not exist, degrees of anxiety cannot be 
quantified objectively and the subjective measures of a 
study like this could not be correlated and might lose 
scientific confidence. In our model, a validity analysis of 
“test-retest reliability” and “internal consistency” (Cron- 
bach’s α) between doctors was not assessed, and so the 
presence of sufficient reliability and validity in this mod-
el might be doubtful at this stage. If we performed the 
same procedure with new data, it is very likely that dif-
ferent tendencies might be identified. Therefore, the ex-
tent to which the results of this paper could be applicable 
may be limited only to our present data. For this reason, 
future studies conducted with sufficiently large samples 
obtained randomly are necessary. 
We anticipate that our present results will serve as a 
useful reference for clinicians attempting to devise an 
evaluation scale, and that further research will focus on 
the optimal method with rigorous methodology to inves-
tigate the utility of the VAS. 
5. CONCLUSION 
There was a good linear relationship between the LSAS 
score and patients’ global self-impressions (patient VAS 
score). The LSAS scores and doctors’ global impressions 
(doctor VAS score) were less well-correlated. There may 
be circumstances where patient VAS scores could subs-
titute for the LSAS to reduce the time and effort for pa-
tients. Certain demographic features may be predictive of 
this, as future studies may show. 
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